Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.

British journal of cancer - 8 Nov 2016

Zaaijer Leendert H, van Doorn Helena C, Mourits Marian J E, van Beurden Marc, de Hullu Joanne A, Adank Muriel A, van Lonkhuijzen Luc R C W, Vasen Hans F A, Slangen Brigitte F M, Gaarenstroom Katja N, Zweemer Ronald P, Vencken Peggy M L H, Seynaeve Caroline, Kriege Mieke

Abstract excerpt

BACKGROUND: It is unknown whether a history of breast cancer (BC) affects the outcome of BRCA1/2-associated epithelial ovarian cancer (EOC). This was investigated in the current analysis. METHODS: We included 386 BRCA1/2-associated EOC patients diagnosed between 1980 and 2015. Progression-free survival (PFS), progression-free interval (PFI), overall survival (OS) and ovarian cancer-specific survival (OCSS) were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Carcinoma, Ovarian Epithelial

Share to Disease-Free Survival

Share to Neoplasms, Glandular and Epithelial

Share to Ovarian Neoplasms

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 27755534
DOI: 10.1038/bjc.2016.333
PMCID: PMC5104898

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.PMID 27755534Read ↗

Breast cancer surveillance following ovarian cancer in BRCA mutation carriers.Semantic proximity Read ↗

Breast cancer incidence and subtype patterns among BRCA-mutated ovarian cancer patients: a systematic review and meta-analysis.Semantic proximity Read ↗

Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer.Semantic proximity Read ↗

Breast Cancer Surveillance Following Ovarian Cancer in BRCA Mutation Carriers.Semantic proximity Read ↗

Effects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysis.Semantic proximity Read ↗

Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21).Semantic proximity Read ↗

BRCA1 mutation in breast cancer patients: Analysis of prognostic factors and survivalSemantic proximity Read ↗

The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers.Semantic proximity Read ↗

Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant.Semantic proximity Read ↗

Association between BRCA mutational status and survival in patients with breast cancer: a systematic review and meta-analysis.Semantic proximity Read ↗

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypesSemantic proximity Read ↗

Outcomes and risk of subsequent breast events in breast-conserving surgery patients with BRCA1 and BRCA2 mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.